Mir-25 is a potential treatment target for myocardial ischemic-reperfusion injury.
作者信息
Yang Shang-Feng, Huang Po-Hsun
机构信息
Division of Nephrology, Department of Medicine, Cheng Hsin General Hospital, Taipei, Taiwan, ROC.
Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
出版信息
J Chin Med Assoc. 2020 May;83(5):419-420. doi: 10.1097/JCMA.0000000000000295.
Abstract
摘要
Zotero 插件